The Effects of a GLP-1 Analog on Glucose Homeostasis in Type 2 Diabetes Mellitus Quantified by an Integrated Glucose Insulin Model

In recent years, several glucagon-like peptide-1 (GLP-1)-based therapies for the treatment of type 2 diabetes mellitus (T2DM) have been developed. The aim of this work was to extend the semimechanistic integrated glucose-insulin model to include the effects of a GLP-1 analog on glucose homeostasis i...

Descripción completa

Detalles Bibliográficos
Autores principales: Røge, RM, Klim, S, Ingwersen, SH, Kjellsson, MC, Kristensen, NR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369758/
https://www.ncbi.nlm.nih.gov/pubmed/26225223
http://dx.doi.org/10.1002/psp4.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369758/
https://www.ncbi.nlm.nih.gov/pubmed/26225223
http://dx.doi.org/10.1002/psp4.11

Ejemplares similares